Abstract
Many aspects of epilepsy in mitochondrial disorders (MDs) need to be further clarified. To this aim, we explored retrospectively a cohort of individuals with MDs querying the “Nationwide Italian Collaborative Network of Mitochondrial Diseases” (NICNMD) database (1467 patients included since 2010 to December 2016). We collected information on age at epilepsy onset, seizure type and frequency, genetic findings, and antiepileptic drugs (AEDs). At the time of our survey, 147/1467 (10%) patients in the NICNMD database had epilepsy. Complete information was available only for 98 patients, 52 males and 46 females, aged 5–92 years (mean age 40.4 ± 18.4; 14/98 children/teenagers and 84 adults). Epilepsy was the presenting feature of MD in 46/98 (47%) individuals, with onset at a median age of 19 years (range, 0.2–68; < 3 years in 14/97 (14%), 3–19 years in 36/97 (37%), > 19 years in 47/97 (49%)). Moreover, 91/98 patients (93%) displayed multiple seizures, with daily or weekly frequency in 25/91 (28%). Interictal EEG was abnormal in 70/78 (90%) patients, displaying abnormal background (47/70; 67%) and/or interictal paroxysms (53/70; 76%). Eighty of 90 patients (89%) displayed a 50–100% reduction of seizures on AEDs; levetiracetam was the most commonly used. Forty-one patients (42%) carried the m.3243A>G mutation, 16 (16%) the m.8344A>G, and 9 (9%) nuclear DNA (nDNA) mutations. Individuals with early-onset seizures mainly carried nDNA mutations and had a more severe epilepsy phenotype, higher seizure frequency, and disorganized background EEG activity. A better definition of epilepsy in MDs may foster the diagnostic workup, management, and treatment of affected patients, and allow more homogeneous patient stratification.
Similar content being viewed by others
References
Schapira AH (2006) Mitochondrial disease. Lancet 368(9529):70–82
Gorman GS, Chinnery PF, DiMauro S et al (2016) Mitochondrial diseases. Nat Rev Dis Primers 2:16080
Filosto M, Mancuso M (2007) Mitochondrial diseases: a nosological update. Acta Neurol Scand 115(4):211–221
Matricardi S, Canafoglia L, Ardissone A et al (2019) Epileptic phenotypes in children with early-onset mitochondrial diseases. Acta Neurol Scand 140(3):184–193
Whittaker RG, Devine HE, Gorman GS, Schaefer AM, Horvath R, Ng Y, Nesbitt V, Lax NZ, McFarland R, Cunningham MO, Taylor RW, Turnbull DM (2015) Epilepsy in adults with mitochondrial disease: a cohort study. Ann Neurol 78(6):949–957
Bindu PS, Sonam K, Govindaraj P et al (2018) Outcome of epilepsy in patients with mitochondrial disorders: phenotype genotype and magnetic resonance imaging correlations. Clin Neurol Neurosurg 164:182–189
El Sabbagh S, Lebre AS, Bahi-Buisson N et al (2010) Epileptic phenotypes in children with respiratory chain disorders. Epilepsia. 51(7):1225–1235
Lee HF, Chi CS, Tsai CR, Chen CH (2011) Epileptic seizures in infants and children with mitochondrial diseases. Pediatr Neurol 45(3):169–174
Chevallier JA, Von Allmen GK, Koenig MK (2014) Seizure semiology and EEG findings in mitochondrial diseases. Epilepsia. 55(5):707–712
Mancuso M, Orsucci D, Angelini C et al (2014) The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender? J Neurol 261(3):504–510
Mancuso M, Orsucci D, Angelini C, Bertini E, Carelli V, Comi GP, Minetti C, Moggio M, Mongini T, Servidei S, Tonin P, Toscano A, Uziel G, Bruno C, Caldarazzo Ienco E, Filosto M, Lamperti C, Martinelli D, Moroni I, Musumeci O, Pegoraro E, Ronchi D, Santorelli FM, Sauchelli D, Scarpelli M, Sciacco M, Spinazzi M, Valentino ML, Vercelli L, Zeviani M, Siciliano G (2013) Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation. Neurology. 80(22):2049–2054
Mancuso M, Orsucci D, Angelini C et al (2015) Redefining phenotypes associated with mitochondrial DNA single deletion. J Neurol 262(5):1301–1309
Mancuso M, Orsucci D, Angelini C, Bertini E, Catteruccia M, Pegoraro E, Carelli V, Valentino ML, Comi GP, Minetti C, Bruno C, Moggio M, Ienco EC, Mongini T, Vercelli L, Primiano G, Servidei S, Tonin P, Scarpelli M, Toscano A, Musumeci O, Moroni I, Uziel G, Santorelli FM, Nesti C, Filosto M, Lamperti C, Zeviani M, Siciliano G (2014) Myoclonus in mitochondrial disorders. Mov Disord 29(6):722–728
Orsucci D, Angelini C, Bertini E, Carelli V, Comi GP, Federico A, Minetti C, Moggio M, Mongini T, Santorelli FM, Servidei S, Tonin P, Ardissone A, Bello L, Bruno C, Ienco EC, Diodato D, Filosto M, Lamperti C, Moroni I, Musumeci O, Pegoraro E, Primiano G, Ronchi D, Rubegni A, Salvatore S, Sciacco M, Valentino ML, Vercelli L, Toscano A, Zeviani M, Siciliano G, Mancuso M (2017) Revisiting mitochondrial ocular myopathies: a study from the Italian network. J Neurol 264(8):1777–1784
Mancuso M, Orsucci D, Angelini C et al (2016) Mitochondrial neuropathies: a survey from the large cohort of the Italian Network. Neuromuscul Disord 26(4–5):272–276
Filosto M, Cotti Piccinelli S, Lamperti C et al (2019) Muscle pain in mitochondrial diseases: a picture from the Italian network. J Neurol 266(4):953–959
Musumeci O, Barca E, Lamperti C et al (2019) Lipomatosis incidence and characteristics in an Italian cohort of mitochondrial patients. Front Neurol 10:160
Fisher RS, Cross JH, French JA et al (2017) Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia. 58(4):522–530
European Medicines Agency (2010) Guideline on clinical investigation of medicinal products in the treatment of epileptic disorders. European Medicines Agency, London (CPM/EWP/566/98/rev 2)
DiMauro S, Schon EA, Carelli V, Hirano M (2013) The clinical maze of mitochondrial neurology. Nat Rev Neurol 9(8):429–444
Finsterer J, Mahjoub SZ (2013) Presentation of adult mitochondrial epilepsy. Seizure. 22(2):119–123
Khurana DS, Salganicoff L, Melvin JJ et al (2008) Epilepsy and respiratory chain defects in children with mitochondrial encephalopathies. Neuropediatrics. 39(1):8–13
Kang HC, Lee YM, Kim HD, Lee JS, Slama A (2007) Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia. 48(1):82–88
Lee YM, Kang HC, Lee JS, Kim SH, Kim EY, Lee SK, Slama A, Kim HD (2008) Mitochondrial respiratory chain defects: underlying etiology in various epileptic conditions. Epilepsia. 49(4):685–690
Canafoglia L, Franceschetti S, Antozzi C, Carrara F, Farina L, Granata T, Lamantea E, Savoiardo M, Uziel G, Villani F, Zeviani M, Avanzini G (2001) Epileptic phenotypes associated with mitochondrial disorders. Neurology. 56(10):1340–1346
Bindoff LA, Engelsen BA (2012) Mitochondrial diseases and epilepsy. Epilepsia. 53(Suppl 4):92–97
Serra G, Piccinnu R, Tondi M et al (1996) Clinical and EEG findings in eleven patients affected by mitochondrial encephalomyopathy with MERRF-MELAS overlap. Brain Dev 18(3):185–191
Steele HE, Chinnery PF (2015) Mitochondrial causes of epilepsy: evaluation, diagnosis, and treatment. Semin Neurol 35(3):300–309
Avula S, Parikh S, Demarest S, Kurz J, Gropman A (2014) Treatment of mitochondrial disorders. Curr Treat Options Neurol 16(6):292
Hikmat O, Eichele T, Tzoulis C, Bindoff LA (2017) Understanding the epilepsy in POLG related disease. Int J Mol Sci 18(9)
Anagnostou ME, Ng YS, Taylor RW, McFarland R (2016) Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: a clinical and molecular genetic review. Epilepsia. 57(10):1531–1545
Mancuso M, Galli R, Pizzanelli C, Filosto M, Siciliano G, Murri L (2006) Antimyoclonic effect of levetiracetam in MERRF syndrome. J Neurol Sci 243:97–99
Acknowledgments
We are indebted to Dr. Catherine J. Wrenn for the expert editing of the manuscript and critical advice.
Funding
This study received financial support from the Italian Ministry of Health-Ricerca Corrente, MITO-NEXT, Mit-OMICS (to FMS) and 5X1000 (to FS), Fondazione Telethon (Grant numbers GUP09004 and GSP16001), and the patients’ association MITOCON, which also provided the web-platform assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was conducted in accordance with the standards and approved by the ethics committees of all the centers involved in the study; these centers obtained written informed consent from all participating patients or their legal guardians, in accordance with the ethical standards of the 1964 Declaration of Helsinki.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ticci, C., Sicca, F., Ardissone, A. et al. Mitochondrial epilepsy: a cross-sectional nationwide Italian survey. Neurogenetics 21, 87–96 (2020). https://doi.org/10.1007/s10048-019-00601-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10048-019-00601-5